Researchers found that the Multimer Detection System-Oligomeric amyloid-beta blood test, which measures amyloid-beta oligomerization, yielded 100% sensitivity and 92% specificity in identifying people at risk for developing Alzheimer's disease. The findings in the Journal of Alzheimer's Disease suggest that amyloid-beta oligomerization "is expected to be of great help in treating dementia," said researcher Youn Young-chul.
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.